Aesthetics at the International Dental Show (IDS) 2017: Ceramic innovations inspire
Precoloured veneering ceramics - infiltration method, staining techniques - economic production options for aesthetic restorations - a central theme of IDSPeople, who have beautiful eyes and lovely teeth, are beautiful. Because that is what the eye of the onlooker perceives first. The proportions have to be right and form a harmonious whole. As far as teeth are concerned, the dental industry has created a host of innovative methods and products over the past decades, which narrow the gap more and more between a high ideal and the achievable reality. These include modern diagnosis and therapy options (i.e. face scanners, ba...
Source: Dental Technology Blog - September 14, 2016 Category: Dentistry Source Type: news
Why Taller People May Be Better At Judging How Far Away Things Are
Tall people are better than short people at gauging how far away they are from objects in the middle distance, a new study reports. The researchers say the results are evidence for the idea that people’s spatial perception abilities are influenced by their height, and develop over time.
The human brain depends on a certain model to provide “the best guess of where objects could be located,” said study co-author Teng Leng Ooi, a professor of optometry at The Ohio State University.
That model, or “intrinsic bias,” is typically revealed when people have very little information about where an obje...
Source: Healthy Living - The Huffington Post - September 6, 2016 Category: Consumer Health News Source Type: news
MassDevice.com +5 | The top 5 medtech stories for August 18, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. HeartWare recalls some HVAD implantable heart pumps on electrical fault risk
HeartWare International this week recalled some of its HVAD implantable heart pumps on the risk of electrical faults from driveline contamination.
The ...
Source: Mass Device - August 18, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Should Women Have Breast Implants Removed?
It was a story with a bit of irony, as well as ominous health warnings.
Crystal Hefner, the 30-year-old wife of Playboy magazine mogul Hugh Hefner, announced in a story in People magazine last month that she'd had her breast implants removed because they were making her sick.
Hefner posted a photo of her post-surgery self on Instagram with the caption, "Using 2016 to reclaim my health and embrace and love myself for the real me."
The former model, now a DJ, was diagnosed a few months back with Lyme disease. Her symptoms included intolerance to foods and beverages as well as back, neck, and shoulder pain.
Hefner also su...
Source: Healthy Living - The Huffington Post - August 2, 2016 Category: Consumer Health News Source Type: news
MassDevice.com +5 | The top 5 medtech stories for July 14, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Endotronix raises $32m Series C for wireless heart monitor
Endotronix said today that it raised a $32 million Series C round for the wireless heart monitor it’s looking to commercialize.
Participants in the round included exi...
Source: Mass Device - July 14, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Love Will Be The Death Of Us
Notes On The End Of My Marriage
Author's note: This is a sincere attempt to learn the end of a relationship, a final love letter, of sorts. Some of the names have been changed and my former partner has consented its publication.
8.2011 -- The Beginning
There is no easy way to masturbate into a small plastic container. I find this out as I approach climax, simultaneously holding the container in place while stoking my erection with the other hand. Truth be told, I don't actually masturbate very often -- perhaps something about the act I continue to find shameful.
Suddenly: a rush of white light and a moment of fleeting ...
Source: Healthy Living - The Huffington Post - June 25, 2016 Category: Consumer Health News Source Type: news
Surgery-obsessed model Pixee Fox gets implants to make her eyes 'cartoon green'
Pixee Fox, 26, from North Carolina, has just had her 19th cosmetic procedure after dreaming of changing her eye colour since she was a little girl. She has also had cosmetic surgery totalling over £80,000. (Source: the Mail online | Health)
Source: the Mail online | Health - June 2, 2016 Category: Consumer Health News Source Type: news
Presbia touts 6-month data for Flexivue microlens
Presbia (NSDQ:LENS) today reported interim data from a U.S. pivotal trial of its Flexivue microlens, touting an average gain of 5 lines of uncorrected near visual acuity and 99% maintenance of binocular uncorrected distance vision.
The company reports a total of 421 subjects have been implanted with the Flexivue microlens in the trial, which is being carried out as the company seeks FDA premarket approval. Presbia said it is planning for a final PMA module submission in September 2017.
An average gain of 5 lines of uncorrected near visual acuity in treated eyes, as well as a 99% rate of maintained binocular uncorrected dis...
Source: Mass Device - May 18, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Presbia Source Type: news
New implant set to join fight against U.S. painkiller epidemic
(Reuters) – Two companies are on the cusp of taking a new treatment for opioid addiction to the U.S. market at a time when lawmakers are seeking ways to arrest an epidemic of heroin and painkiller abuse that kills 78 Americans every day.
Titan Pharmaceuticals Inc and privately owned Braeburn Pharmaceuticals have together developed a matchstick-sized implant that analysts expect will be approved next month, despite mixed reviews.
Implanted into the arm, the treatment is designed to be less vulnerable to abuse or illicit resale than the oral drugs that are currently used to treat opioid addiction.
The market for the implan...
Source: Mass Device - April 29, 2016 Category: Medical Equipment Authors: MassDevice Tags: Pain Management Source Type: news
What to Expect When You're... Still Not Expecting
IVF Isn't About the Journey, It's About the Destination
While some women may share their birth stories, I wanted to share our fertility story.
Translating my mind's weavings into words on paper has helped me weather numerous storms, but throughout 2015 -- a year marred by a lot of heartbreak and too many hormonal injections -- when I've needed this kind of therapy the most, I maintained silence on a subject that hit me like a piece of fallen scaffolding. Instead, I relied heavily on the physical support of my husband, family and friends, all for whom I am extremely grateful. With each setback along this grueling and at ...
Source: Healthy Living - The Huffington Post - April 28, 2016 Category: Consumer Health News Source Type: news
Many Lens Implant Patients May Develop Cataracts Within 10 YearsMany Lens Implant Patients May Develop Cataracts Within 10 Years
Many patients who get lens implant surgery to correct vision problems may develop cataracts or elevated pressure around the eyes within 10 years after the procedures, a Swiss study suggests. Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - March 7, 2016 Category: Opthalmology Tags: Ophthalmology News Source Type: news
Many lens implant patients may develop cataracts within 10 years
(Reuters Health) - Many patients who get lens implant surgery to correct vision problems may develop cataracts or elevated pressure around the eyes within 10 years after the procedures, a Swiss study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 4, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
RIP medical device pioneer Alfred Mann | Personnel Moves
Alfred Mann, a medical device entrepreneur who helped develop several groundbreaking technologies, died yesterday at age 90, shortly after stepping down from a pair of companies he founded.
Mann founded 17 companies over his 70-year career, in industries ranging from aerospace to medtech, according to the L.A. Times.
After Johns Hopkins University researchers in 1969 asked him to help create a longer-lasting pacemaker, Mann turned his eye from the aerospace industry to medtech, according to the Times. In later years he founded several medical device companies, including MiniMed, which Medtronic (NYSE:MDT) acquired for $3....
Source: Mass Device - February 26, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Business/Financial News Abiomed Inc. Advanced Bionics LLC ConMed Corp. Corindus Vascular Robotics Gynesonics Hansen Medical Inc. LifeImage mannki Medtronic MedX Health Penumbra Inc. Personnel Moves Second Sight Medical Products I Source Type: news
Behind the Headlines' Top Five of Top Fives 2015
In this study, researchers wanted to see why this is and if there could be any human applications.Researchers collected white blood cells from African and Asian elephants. They found that elephants have at least 20 copies of a gene called TP53. TP53 is known to encourage cell "suicide" when DNA is damaged, stopping any potential cancer in its tracks. In contrast, humans are thought to have only a single copy of the TP53 gene.Of course the big question – the elephant in the room, if you will – is how we can boost TP53 activity in humans to stimulate a similar protective effect. The simple answer is: we don't k...
Source: NHS News Feed - December 24, 2015 Category: Consumer Health News Tags: QA articles Medical practice Special reports Source Type: news
Behind the Headlines Top Five of Top Fives 2015
In this study, researchers wanted to see why this is and if there could be any human applications.
Researchers collected white blood cells from African and Asian elephants. They found elephants have at least 20 copies of a gene called TP53. TP53 is known to encourage cell "suicide" when DNA is damaged, stopping any potential cancer in its tracks. In contrast, humans are thought to have only a single copy of the TP53 gene.
Of course the big question – the elephant in the room, if you will – is how we can boost TP53 activity in humans to stimulate a similar protective effect. The simple answer is: we don't know...
Source: NHS News Feed - December 24, 2015 Category: Consumer Health News Tags: QA articles Medical practice Special reports Source Type: news
